Clinical eligibility for brand-name GLP-1 medications generally requires an adult patient to have a body mass index (BMI) of 30 or greater, or a BMI of 27 or higher paired with a weight-related health condition such as high blood pressure
Dose escalation resets One thing to know: dose increases can temporarily restart some of these patterns
SEQUENCE: H-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-NH2 ONE-LETTER SEQUENCE: HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR-NH2 MOLECULAR FORMULA: C 149 H 226 N 40 O 45 MOLECULAR WEIGHT: 3297.68 STORAGE CONDITIONS: -20 5 C CAS REGISTRY NUMBER: [107444-51-9] SYNONYMS: GLP-1 fragment, Proglucagon (78-107) amide (human, bovine, guinea pig, mouse, rat), Preproglucagon (98-127) amide (human, bovine, guinea pig, mouse, rat), Glucagon-Like Peptide 1 (7-36) amide (human, bovine, guinea pig, mouse, rat) RESEARCH AREA: Diabetes REFERENCES: G
Nonreturnable Due to regulatory requirements, once shipped, this product cannot be returned or refunded